This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Presenting quantitative information increased participants’ gist and verbatim recall of drug efficacy. ” Uh…no.
00:55 Today we have another special guest and he goes by the name of Jasper Freeman. They build up fluid in their ankles and mostly in the interstitial areas which sometimes you can’t even see, and the only recourse for doctors and for patients was to go into the hospital. Hello and welcome to the Medical Sales Podcast.
Before 2020, the landscape of drug marketing involved following drug approvals by the Food and DrugAdministration ( FDA ), finding which patient population would benefit from therapy, and visiting specializeddoctors in-person to advertise its advantages compared to current guidelines.
Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and DrugAdministration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. So, here they are: 1.
Lee Aase: And our, and this is in in collaboration with a high school classmate of mine who's a primary care, doctor. Lee Aase: which is very much like the administrator, physician, leadership, partnership that we had at Mayo Clinic. And hospitals notoriously conservative and doctors far more so. Lee Aase: Yeah. Lee Aase: Yeah.
The CE experience for this Podcast is powered by CMEfy – click here to reflect and earn credits: [link] — Watch the episode here Listen to the podcast here Cardiovascular Medical Device Sales With Marc Toth In this episode, we have with us another special guest and he goes by the name of Marc Toth. Who is Marc Toth? Good for them.
The US Food and DrugAdministration has approved the use of iTFlow® in blood flow analysis. was founded by two doctors with a mission to “change cardiology with blood flow analysis.” The FDA approval of iTFlow® will enable healthcare professionals to make more precise and effective decisions in patient care.
Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and DrugAdministration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. So, here they are: 1.
Food & DrugAdministration (FDA) classifies medical devices. Class II: requires general controls and special controls with and without exemptions and poses a moderate risk. Consultation and decision-making: where the patient is speaking with their doctor and exploring different options. .
The US Food and DrugAdministration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS).
You know when they are trying to push a drug and white-knuckling it. You ask the hospital administrators to figure out the financial aspects of that side of it. What drugs are we using? This office or rep prescribed this drug and this is what I want you to know about this drug.”. You do not even have to say it.
48:12 What is Uri Gorenseeing that is special in the Israeli Digital Health ecosystem? It's become the main thing that the doctors are looking at now. And I think also you what you see is doctors that grew on this kind of, bedrock, are more open for this because this is now part of the culture. And it's shifting the power.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content